TD Cowen lowered the firm’s price target on Acadia Healthcare (ACHC) to $22 from $25 and keeps a Buy rating on the shares. The firm updated its model and estimates to reflect its PLGL-related guidance cut.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACHC:
- Maintaining a Buy on Acadia Healthcare: Valuation Upside and Resilient Medium-Term Growth Despite PLGL-Driven 2025 Reset
- Acadia Healthcare price target lowered to $17 from $19 at RBC Capital
- Acadia Healthcare Reaffirms 2025 Financial Guidance at Conference
- Acadia Healthcare price target lowered to $17 from $22 at Mizuho
- Acadia Healthcare price target lowered to $14 from $17 at Barclays